State of AI testing 2026: adoption, ROI, where it stalled.

The sources, briefly

Capgemini World Quality Report (capgemini.com) surveys hundreds of organisations annually on quality assurance practices, with a substantial section on AI in testing in recent editions. The strength is breadth across industries; the weakness is reliance on self-reporting from senior QA leaders.

Tricentis State of QA Report (tricentis.com) surveys QA practitioners on tools, practices, and pain points. Strong on practitioner-level detail; weighted toward respondents in the Tricentis ecosystem.

DORA State of DevOps Report (dora.dev) does not focus on AI testing specifically but reports on the broader devops metrics (deployment frequency, lead time, change failure rate, MTTR) that AI testing intends to improve. Strong on outcome measurement; lighter on tool specifics.

GitHub Octoverse (github.blog/news-insights/octoverse) surveys developer behaviour through GitHub activity data. Strong on what developers are actually doing; lighter on testing specifically.

Where the sources agree

Adoption of some form of AI in testing is widespread. All four sources report that the majority of organisations have adopted AI in at least one testing-related workflow by 2026. Copilot-style code completion is the most common entry point; dedicated AI testing platforms are a smaller but growing slice.

AI augments rather than replaces the QA function. Both Capgemini and Tricentis explicitly report this; DORA implies it through team-composition metrics; Octoverse shows continued growth in developer-side AI tool usage without corresponding QA-headcount contraction. The replacement narrative does not match the data.

Operational maturity is the bottleneck. Teams with strong existing testing practices get more value from AI augmentation than teams with weak existing practices. AI is a multiplier, not a substitute.

ROI is real but modest at the team level. Productivity gains of 10 to 30 percent on specific tasks are common; transformational change is rare. Teams reporting larger gains tend to have specific high-leverage situations rather than representative experiences.

Where the sources disagree

The pace of adoption. Capgemini reports faster adoption of AI in testing than Tricentis. The disagreement is partly definitional (what counts as adoption) and partly sampling (Capgemini surveys broader, Tricentis surveys deeper). The honest read is somewhere between the two single numbers.

The role of vendor platforms versus in-house build. Capgemini reports vendor platforms as the dominant adoption path. Octoverse data on AI library usage in test code suggests substantial in-house building, particularly at larger engineering organisations. Both are right for different segments of the market. See build vs buy AI testing for the framing.

Whether productivity gains translate to deployment-frequency improvement. DORA data on deployment frequency and lead time does not show the dramatic acceleration that AI-testing-tool marketing implies. Either the gains are not yet showing up in the DORA metrics, or the gains are smaller in real terms than they appear in survey self-reports.

Where adoption has stalled

Regulated industries. Healthcare, financial services, defence. The vendor-risk review process for AI tools that may handle sensitive data is slow and conservative. Even when the testing tools themselves do not handle production data, the categorisation as "AI" triggers procurement processes that did not exist for traditional testing tools.

Legacy codebases. Teams with large, under-tested legacy codebases would in theory benefit most from AI test-generation tools like Diffblue Cover. In practice, the operational lift to integrate the tool, review generated tests, and maintain the resulting suite is meaningful, and the ROI is delayed. Some teams find the lift exceeds the per-team budget in the short term.

Low-priority testing functions. Organisations where testing was already low-priority do not suddenly become testing-mature when AI is added. The AI augmentation has nothing to leverage; the team continues to ship under-tested software, now with AI-assisted under-testing.

The honest 2026 to 2027 trajectory

Continued growth in foundation-model capability will lift the ceiling on what AI testing tools can do. Vendor platforms that lock in current model versions through long contracts may underperform versus open-source-leaning stacks that follow the model frontier.

Operational maturity will continue to be the bottleneck. The teams that get value from AI testing in 2027 will be the teams that already get value in 2026, plus a long tail of teams that build their operational discipline alongside the tool adoption.

Vendor consolidation is plausible at the platform layer. Several mid-market platforms in the self-healing and agentic categories will likely be acquired by the larger devops or quality vendors. Buyers should weigh acquisition risk in their procurement decisions over multi-year contracts.

The senior QA function will continue to grow more leveraged, not less needed. The engineer who can design testing strategy, interpret AI findings, and run incident response is the durable role.

What to do about it

For teams with mature testing: continue investing, layer AI where it leverages existing strength, measure the ROI honestly, do not over-rotate based on marketing.

For teams with immature testing: invest in the operational discipline first, AI tools second. AI augmentation of a broken testing programme produces a faster-broken testing programme.

For teams in regulated industries: invest in the vendor-risk review process so that AI tools can be evaluated and adopted on a sensible cadence; the alternative is falling further behind as the technology accelerates.

Frequently asked questions

Has AI testing reached majority adoption?

Adoption of some form of AI in testing has reached most organisations by 2026 per the major industry surveys. The depth of adoption varies wildly: some teams use Copilot for occasional test suggestions, others have replaced significant portions of their hand-authored test suites with AI-generated equivalents. The headline numbers conflate these very different states.

Where has adoption stalled?

Adoption has been slower in regulated industries (healthcare, financial services) where vendor-risk review processes lag the technology, in legacy codebases where the operational lift exceeds the per-team ROI in the short term, and in organisations where testing was already a low-priority function (so the AI augmentation has nothing to leverage).

What does ROI actually look like?

The honest published numbers are modest. Most teams report incremental productivity gains (10 to 30 percent) on specific tasks rather than transformational change. The teams reporting larger numbers typically have specific high-leverage situations (massive untested legacy codebases, severe flake problems that AI flake-management addresses) rather than representative experiences.

Will AI replace QA engineers?

The published industry surveys consistently report that AI augments rather than replaces the QA function. The role shifts toward higher-leverage work (test strategy, exploratory testing, agent-result triage, infrastructure decisions) and away from rote test authoring. The headcount math depends on the company; some organisations have grown QA teams, others have held flat while extending coverage.

What is the most important capability shift?

The honest answer is that the most important capability shift is engineering judgement about what AI testing should and should not do. Teams that adopt AI testing thoughtfully (clear about where it helps, disciplined about reviewing output, willing to invest in the surrounding process) see real gains. Teams that adopt AI testing because of FOMO or executive mandate often do not.